Loading…
The Oral β-Lactamase SYN-004, Designed to Protect the Gut Microbiome from Biliary Excreted IV Antibiotics, Efficiently Degrades Intestinal Ceftriaxone in Two Phase 2a Clinical Trials
Saved in:
Published in: | Open forum infectious diseases 2016-12, Vol.3 (suppl_1) |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 2328-8957 2328-8957 |
DOI: | 10.1093/ofid/ofw172.1060 |